chr20-17621719-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001365613.2(RRBP1):c.3295C>T(p.His1099Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00203 in 1,613,682 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 25 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 20 hom. )
Consequence
RRBP1
NM_001365613.2 missense
NM_001365613.2 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 3.69
Genes affected
RRBP1 (HGNC:10448): (ribosome binding protein 1) This gene encodes a ribosome-binding protein of the endoplasmic reticulum (ER) membrane. Studies suggest that this gene plays a role in ER proliferation, secretory pathways and secretory cell differentiation, and mediation of ER-microtubule interactions. Alternative splicing has been observed and protein isoforms are characterized by regions of N-terminal decapeptide and C-terminal heptad repeats. Splicing of the tandem repeats results in variations in ribosome-binding affinity and secretory function. The full-length nature of variants which differ in repeat length has not been determined. Pseudogenes of this gene have been identified on chromosomes 3 and 7, and RRBP1 has been excluded as a candidate gene in the cause of Alagille syndrome, the result of a mutation in a nearby gene on chromosome 20p12. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0022284985).
BP6
Variant 20-17621719-G-A is Benign according to our data. Variant chr20-17621719-G-A is described in ClinVar as [Benign]. Clinvar id is 777534.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.011 (1671/152382) while in subpopulation AFR AF = 0.0368 (1530/41584). AF 95% confidence interval is 0.0353. There are 25 homozygotes in GnomAd4. There are 825 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRBP1 | NM_001365613.2 | c.3295C>T | p.His1099Tyr | missense_variant | Exon 15 of 25 | ENST00000377813.6 | NP_001352542.1 | |
RRBP1 | NM_001042576.2 | c.1996C>T | p.His666Tyr | missense_variant | Exon 16 of 26 | NP_001036041.2 | ||
RRBP1 | NM_004587.3 | c.1996C>T | p.His666Tyr | missense_variant | Exon 15 of 25 | NP_004578.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0109 AC: 1665AN: 152264Hom.: 26 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1665
AN:
152264
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00294 AC: 735AN: 249660 AF XY: 0.00212 show subpopulations
GnomAD2 exomes
AF:
AC:
735
AN:
249660
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1611AN: 1461300Hom.: 20 Cov.: 33 AF XY: 0.000933 AC XY: 678AN XY: 726978 show subpopulations
GnomAD4 exome
AF:
AC:
1611
AN:
1461300
Hom.:
Cov.:
33
AF XY:
AC XY:
678
AN XY:
726978
show subpopulations
African (AFR)
AF:
AC:
1220
AN:
33480
American (AMR)
AF:
AC:
123
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26130
East Asian (EAS)
AF:
AC:
0
AN:
39696
South Asian (SAS)
AF:
AC:
6
AN:
86254
European-Finnish (FIN)
AF:
AC:
0
AN:
52970
Middle Eastern (MID)
AF:
AC:
15
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
94
AN:
1111950
Other (OTH)
AF:
AC:
152
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
87
175
262
350
437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0110 AC: 1671AN: 152382Hom.: 25 Cov.: 33 AF XY: 0.0111 AC XY: 825AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
1671
AN:
152382
Hom.:
Cov.:
33
AF XY:
AC XY:
825
AN XY:
74518
show subpopulations
African (AFR)
AF:
AC:
1530
AN:
41584
American (AMR)
AF:
AC:
105
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15
AN:
68042
Other (OTH)
AF:
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
85
169
254
338
423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
177
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
458
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 18, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T;.;T;.;T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N;N;.;.;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N;N;N;N;N
REVEL
Benign
Sift
Uncertain
.;.;D;D;D;D;D
Sift4G
Benign
T;D;D;D;D;D;D
Polyphen
0.0090, 0.21
.;.;B;B;B;B;.
Vest4
MVP
MPC
0.12
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
Loading publications...